GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Scorpius Holdings SCPX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Scorpius Holdings — daily SCPX Delayed
Market value
$12,228
Last close × shares
Volume
1.2k
Shares, 9 Nov 2026

About Scorpius Holdings

Its shares trade under the ticker SCPX. It has been listed since 24 July 2013. In the fiscal year to 31 December 2024, it reported revenue of $6.2m and a net loss of $32.8m. At that date it held total assets of $39.2m and shareholders' equity of $6.3m.

Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Morrisville, North Carolina. The company went IPO on 2013-07-24. The firm is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT). Using its ImPACT platform technology, the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a potential treatment for patients with non-small cell lung cancer (NSCLC). Using its ComPACT platform technology, it has developed HS-120 as a potential treatment for NSCLC. The company is conducting a Phase II trial of HS-410 in patients with NMIBC, and a Phase Ib trial of HS-110, in combination with nivolumab (Opdivo) to treat patients with NSCLC.

Figures and description from our data supplier, not checked against the company's own report.

More about Scorpius Holdings →

Latest on Scorpius Holdings

Our reporting

We have not reported on Scorpius Holdings yet.

Next results

13 Nov 2026

Due on 13 Nov 2026. Analysts expect earnings of -54.67 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Scorpius Holdings's ticker?

Scorpius Holdings trades as SCPX on its US listing, under ISIN US42237K5083.

What was Scorpius Holdings's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

When does Scorpius Holdings next report results?

Results are expected on 13 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.